An Analysis of Fentanyl-Related Deaths in the Second Half of 2016
Fentanyl-Related Deaths Has Increased. Every week, the Centers for Disease Control and Prevention (CDC) releases the Morbidity and Mortality Weekly Report (MMWR). In the November 3, 2017, edition, the authors discuss the opioid epidemic. Since 2013, the number of deaths caused by opioid overdoses has increased … [Read more...] about An Analysis of Fentanyl-Related Deaths in the Second Half of 2016
Industry Payments Linked to Different Prescribing Habits
ProPublica Payments Role In Different Prescribing Habits. A ProPublica analysis looks into whether physicians are more likely to prescribe brand name drugs if they receive payments from drug makers and pharmaceutical companies. Generic medications are introduced to the market after the patent on brand names has expired; they are much … [Read more...] about Industry Payments Linked to Different Prescribing Habits
Hair Analysis has been Flawed over Decades, FBI Says
The use of microscopic hair analysis as evidence against defendants was flawed for over two decades before 2000, the Justice Department and FBI admit. According to the Washington Post, the agencies admit that almost every examiner an elite FBI forensic unit, the FBI Laboratory's microscopic hair comparison unit, gave flawed testimony … [Read more...] about Hair Analysis has been Flawed over Decades, FBI Says
Analysis: Panel urges warning on stents
FDA New Warning On Stents. A Food and Drug Administration advisory panel recommended new warnings Friday for popular medical devices used in millions of patients with cardiovascular disease. Experts said the two brands of drug-coated stents available in the U.S. should carry new warnings that the devices may increase the risk of … [Read more...] about Analysis: Panel urges warning on stents
Bausch & Lomb Plant Analysis to Take Another Month
Officials Are Investigating Bausch & Lomb Plant. The Food and Drug Administration said Friday it could take another month to analyze data from an ongoing inspection of Bausch & Lomb Inc.'s (BOL) Greenville, S.C., plant as part of an effort to locate the source of an outbreak of fungal eye infections associated with … [Read more...] about Bausch & Lomb Plant Analysis to Take Another Month
Celebrex Heart-Attack Risk
Celebrex Heart-Attack Risk. A meta-analysis released Tuesday indicates Pfizer's Celebrex increases the risk of a heart attack by over two-fold and experts are calling for regulatory authorities to respond promptly to the new findings. "It's an important finding that regulators need to consider in future prescriptions of this … [Read more...] about Celebrex Heart-Attack Risk
Analysis: SSRIs’ risk to infants
SSRIs May Be Dangerous To Newborn Infants. The class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) is facing more bad news this week with the release of a study indicating that pregnant women's use of the drugs may be dangerous to their newborn infants. The study, which appears in the February issue … [Read more...] about Analysis: SSRIs’ risk to infants
Whole Milk and Lactose Linked To Ovarian Cancer
High Intakes Of Whole Milk And Lactose May Increase Risk Of Developing Ovarian Cancer. A review and analysis of 21 previous studies, published in the August 5 online issue of the International Journal of Cancer and available via Wiley InterScience at http://www.interscience.wiley.com/journal/ijc, suggests high intakes of whole milk … [Read more...] about Whole Milk and Lactose Linked To Ovarian Cancer
